Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 3/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11730374 | 1.00 | CYP1A2 (0.43) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL29210040 | 1.00 | CYP1A2 (0.43) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL29210028 | 1.00 | CYP1A2 (0.43) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL1337267 | 1.00 | CYP1A2 (0.43) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL1323139 | 0.98 | CYP1A2 (0.45) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL1323177 | 0.98 | CYP1A2 (0.40) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL1324551 | 0.96 | CYP1A2 (0.41) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL17529724 | 0.92 | CYP1A2 (0.46) | CYP1A2CNR1NAAASIGMAR1EPHX1 | |
| SCHEMBL1324618 | 0.90 | CYP1A2 (0.43) | CYP1A2 | |
| SCHEMBL1324499 | 0.83 | CYP1A2 (0.39) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024098840-A1 | ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL | 中国石油化工股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2990114-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | National Institute of Advanced Industrial Science and Technology (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990112-A1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990113-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CYCS, CA7, CA9 | CYP1A2 376/4885CNR1 1112/4885NAAA 265/4885 |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | CYP1A2 376/4885CNR1 1112/4885NAAA 265/4885 |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | EPHX2, CA4, CA9 | CYP1A2 409/4885CNR1 374/4885NAAA 418/4885 |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CA2, PLCB3, PHOSPHO1 | CYP1A2 1281/4885CNR1 307/4885NAAA 349/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | CYP1A2 1649/4885CNR1 1259/4885NAAA 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.